MeiraGTx Holdings Plc (MGTX)
7.98
-0.16
(-1.97%)
USD |
NASDAQ |
Nov 20, 16:00
7.99
+0.01
(+0.13%)
After-Hours: 20:00
MeiraGTx Holdings EPS Diluted (Quarterly) : -0.5286 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.5286 |
| June 30, 2026 | 1.713 |
| March 31, 2026 | -0.5696 |
| December 31, 2025 | 0.186 |
| September 30, 2025 | -0.624 |
| June 30, 2025 | -0.4814 |
| March 31, 2025 | -0.5059 |
| December 31, 2024 | -0.5026 |
| September 30, 2024 | -0.549 |
| June 30, 2024 | -0.7552 |
| March 31, 2024 | -0.3191 |
| December 31, 2023 | 0.3178 |
| September 30, 2023 | -0.7442 |
| June 30, 2023 | -0.5344 |
| March 31, 2023 | -0.6243 |
| September 30, 2022 | -0.8343 |
| June 30, 2022 | -0.7606 |
| March 31, 2022 | -0.6976 |
| December 31, 2021 | -0.223 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.5874 |
| June 30, 2021 | -0.4551 |
| March 31, 2021 | -0.5371 |
| December 31, 2020 | -0.2506 |
| September 30, 2020 | -0.1728 |
| June 30, 2020 | -0.6875 |
| March 31, 2020 | -0.4282 |
| December 31, 2019 | -0.149 |
| September 30, 2019 | -0.3018 |
| June 30, 2019 | -0.6343 |
| March 31, 2019 | -0.6249 |
| December 31, 2018 | -0.7689 |
| September 30, 2018 | -0.5856 |
| June 30, 2018 | -2.29 |
| March 31, 2018 | -0.611 |
| September 30, 2017 | -0.3176 |
| June 30, 2017 | -0.2581 |
| March 31, 2017 | -0.245 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xencor, Inc. | 0.5033 |
| UroGen Pharma Ltd. | -0.0289 |
| Ironwood Pharmaceuticals, Inc. | 0.3558 |
| Viking Therapeutics, Inc. | -1.552 |
| IDEAYA Biosciences, Inc. | -1.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.28M |
| Revenue (Quarterly) | 4.814M |
| Total Expenses (Quarterly) | 56.03M |
| Enterprise Value | 728.34M |
| Gross Profit Margin (Quarterly) | -30.20% |
| Profit Margin (Quarterly) | -1.07K% |
| Earnings Yield | 10.04% |
| Operating Earnings Yield | 25.38% |
| Normalized Earnings Yield | 9.851 |